Explore the vast range of titles available.

Background and Aims Data on the safety and effectiveness of tenofovir alafenamide (TAF) plus peginterferon-alpha (Peg-IFN-α) in children with chronic hepatitis B (CHB) are lacking. The current study aimed to present the characteristics of four pediatric CHB patients who obtained a functional cure by using TAF and Peg-IFN-α. Methods In this case series study initiated in May 2019, ten children who had no clinical symptoms or signs received response-guided (HBV DNA undetectable, hepatitis B e antigen [HBeAg] loss or seroconversion, and hepatitis B surface antigen [HBsAg] loss or seroconversion) and functional cure-targeted (HBsAg loss or seroconversion) TAF (25 mg/d, orally) plus Peg-IFN-α-2b (180 µg/1.73m 2 , subcutaneously, once weekly) in combination (9/10) or sequential (1/10) therapy. The safety and effectiveness of these treatments were monitored. Results As of April 2024, four out of ten children obtained a functional cure after a mean of 31.5 months of treatment, and the other six children are still undergoing treatment. These four cured children, aged 2, 4, 8, and 6 years, were all HBeAg-positive and had alanine aminotransferase levels of 80, 47, 114, and 40 U/L; HBV DNA levels of 71200000, 93000000, 8220, and 96700000 IU/mL; and HBsAg levels of 39442.8, 15431.2, 22, and 33013.1 IU/mL, respectively. During treatment, all the children (10/10) experienced mild or moderate adverse events, including flu-like symptoms, anorexia, fatigue, and cytopenia. Notably, growth retardation (8/10) was the most significant adverse event; and it occurred in three cured children (3/4) treated with combination therapy and was present to a low degree in the other cured child (1/4) treated with sequential therapy. Fortunately, all three cured children recovered to or exceeded the normal growth levels at 9 months posttreatment. Conclusions TAF plus Peg-IFN-α-2b therapy is potentially safe and effective for pediatric CHB patients, which may provide important insights for future clinical practice and study designs targeting functional cures for children with CHB.

INTRODUCTION:The course of maternal antiviral prophylaxis to prevent mother-to-child transmission of hepatitis B virus (HBV-MTCT) varies greatly, and it has not been demonstrated in a randomized controlled study.METHODS:In this multicenter, open-label, randomized controlled trial, eligible pregnant women with HBV DNA of 5.3–9.0 log10 IU/mL who received tenofovir alafenamide fumarate (TAF) from the first day of 33 gestational weeks to delivery (expected 8 week) or to 4 weeks postpartum (expected 12 week) were randomly enrolled at a 1:1 ratio and followed until 6 months postpartum. All infants received standard immunoprophylaxis (hepatitis B immunoglobulin and vaccine). The primary end point was the safety of mothers and infants. The secondary end point was the HBV-MTCT rate of infants at the age of 7 months.RESULTS:Among 119 and 120 intention-to-treat pregnant women, 115 and 116 women were followed until delivery, and 110 and 112 per-protocol mother-infant dyads in 2 groups completed the study. Overall, TAF was well tolerated, no one discontinued the therapy due to adverse events (0/239, 0%, 95% confidence interval [CI] 0%–1.6%), and no infant had congenital defects or malformations at delivery (0/231, 0%, 95% CI 0%–1.6%). The infants' physical development at birth (n = 231) and at 7 months (n = 222) was normal. Furthermore, 97.0% (224/231, 95% CI 93.9%–98.5%) of women achieved HBV DNA <5.3 log10 IU/mL at delivery. The intention-to-treat and per-protocol infants' HBV-MTCT rates were 7.1% (17/239, 95% CI 4.5%–11.1%) and 0% (0/222, 95% CI 0%–1.7%) at the age of 7 months. Comparatively, 15.1% (18/119, 95% CI 9.8%–22.7%) vs 18.3% (22/120, 95% CI 12.4%–26.2%) of women in the 2 groups had mildly elevated alanine aminotransferase levels at 3 months and 6 months postpartum, respectively (P = 0.507); notably, no one experienced alanine aminotransferase flare (0% [0/119, 95% CI 0%–3.1%] vs 0% [0/120, 0%–3.1%]).DISCUSSION:Maternal TAF prophylaxis to prevent HBV-MTCT is generally safe and effective, and expected 8-week prenatal duration is feasible. ClinicalTrials.gov, NCT04850950.

The continuing increase in human activities is causing global changes such as increased deposition of atmospheric nitrogen. There is considerable interest in understanding the effects of increasing atmospheric nitrogen deposition on soil enzyme activities, specifically in terms of global nitrogen cycling and its potential future contribution to global climate change. This paper summarizes the ecological effects of atmospheric nitrogen deposition on soil enzyme activities, including size-effects, stage-effects, site-effects, and the effects of different levels and forms of atmospheric nitrogen deposition. We discuss needs for further research on the relationship between atmospheric nitrogen deposition and soil enzymes.

Dunaliella salina is a unicellular green alga and possesses two types of photolyase: Class II cyclobutane pyrimidine dimers (CPD) photolyase and (6-4) photolyase. The gene of D. salina (6-4) photolyase is the first one found in unicellular organisms. CPD photolyases have been extensively studied but (6-4) photolyases are less understood. Because of the data observed in this study, D. salina (6-4) photolyase is insensitive to high salinity; whether it can tolerate a higher level of salinity than other (6-4) photolyases needs to be studied further. However, evidence is provided that (6-4) photolyases might be highly conserved among different species, not only in the sequence identity but also in the photorepair mechanism.

Control technology of aeroengine has made remarkable development in recent 20 years. In order to meet the needs of high performance, high precision propulsion system control, based on computer technology, microelectronic technology and control theory, the control technology is from traditional hydraulic mechanical control to digital electronic control. Digital electronic control has been a huge success from limited function to the full authority control and from the development test to practical application. In the future it will have more widely application and development in the field of military and civilian aircraft control. This paper mainly discusses the full authority digital electronic control. It shows that the digital electronic engine control has wide application prospect and high application value.

High-speed dynamic balance is a main method to solve the problem of exceeding the aero engine vibration limit. However, with the development of techniques of high performance engine, the rotating speed of a rotor becomes more and more high, which turns into a challenge to balance it. Therefore, balancing the rotor with high speed effectively is very important. How effective the engine rotor of high speed dynamic balance is very important.

The scheme adopts computer testing technology, virtual instrument and virtual system technology to realize the automatic detection for heading and attitude signal conversion equipment of aircraft. It greatly improves the test efficiency. Test time was reduced from 30 minutes to 3 minutes. Based on wavelet analysis and hierarchical decision, program module of connected line identification is design and it improves the reliability of program running. Noisy signals are de-noised by automatic zoom function of wavelet transform and that solves the interference problems of AC power supply.

The optic nerve is a viscoelastic solid-like biomaterial.Its normal stress relaxation and creep properties enable the nerve to resist constant strain and protect it from injury.We hypothesized that stress relaxation and creep properties of the optic nerve change after injury.Moreover,human brain-derived neurotrophic factor or umbilical cord blood-derived stem cells may restore these changes to normal.To validate this hypothesis,a rabbit model of optic nerve injury was established using a clamp approach.At 7 days after injury,the vitreous body received a one-time injection of 50 μg human brain-derived neurotrophic factor or 1 × 106 human umbilical cord blood-derived stem cells.At 30 days after injury,stress relaxation and creep properties of the optic nerve that received treatment had recovered greatly,with pathological changes in the injured optic nerve also noticeably improved.These results suggest that human brain-derived neurotrophic factor or umbilical cord blood-derived stem cell intervention promotes viscoelasticity recovery of injured optic nerves,and thereby contributes to nerve recovery.

Objectives To elucidate the differences in clinical and CT manifestations between abdominal tuberculous lymphadenopathy (ATBL) resulting from hematogenous and non-hematogenous dissemination. Methods A retrospective analysis was conducted on the clinical records and CT data of 178 untreated ATBL patients from January 2012 to March 2023. Patients were categorized into two groups: hematogenous dissemination (75 cases) and non-hematogenous dissemination (103 cases). The clinical characteristics of the two groups of patients were compared, and the CT imaging features of ATBL (such as location, size, and enhancement degree) were evaluated. Statistical analyses were performed using Student’s t-test or Mann-Whitney U test and Chi-squared test to identify significant differences between the groups. Results The study found that the non-hematogenous dissemination group had a higher prevalence of males, younger patients, abdominal distension, and positive tuberculin skin test (TST) results, along with higher CD4 + T cell counts and lymphocyte counts. Conversely, the hematogenous group exhibited more HIV-positive patients, positive results of smear microscopy for acid-fast bacilli (AFB) staining, pleural effusion, and cough and sputum production. Significant differences were noted in the distribution, size, fusion, and enhancement patterns of ATBL between the two groups. ATBL in the hematogenous dissemination group predominantly involved the upper and lower para-aortic regions, the hepatoduodenal ligament, the portocaval space, the hepatogastric ligament, and the iliac vessels region. In contrast, the non-hematogenous dissemination group had more involvement in the mesenteric region. Lymph nodes in the hematogenous dissemination group were larger diameters, with irregular mass fusion and mixed enhancement pattern, while homogeneous enhancement was more common in the non-hematogenous dissemination group. Conclusion There are differences in the clinical and CT manifestations of ATBL caused by hematogenous versus non-hematogenous dissemination.